JWJiannong Wu

Jiannong Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiannong Wu has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Chenjuan Wang

    The First Clinical Medical School of Zhejiang Chinese Medicine University, Hangzhou, China; Department of Pneumology, The 72nd Group Army Hospital, Huzhou University, Huzhou, China

    5 shared publications
  • Mengyuan Shen

    The First Clinical Medical School of Zhejiang Chinese Medicine University, Hangzhou, China

    5 shared publications
  • Rong Zhou

    The First Clinical Medical School of Zhejiang Chinese Medicine University, Hangzhou, China

    5 shared publications
  • Dan-Dan Feng

    Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Intens Care Unit, 54 Post Rd, Hangzhou 310006, Zhejiang, Peoples R China

    2 shared publications
  • Dandan Feng

    Intensive Care Unit, The First Affiliated hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China

    2 shared publications
  • Dongdong Yang

    Department of Emergency Medicine The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine) Hangzhou China

    2 shared publications

Latest Publications

  • Open Access

    Developmental Environmental Chronotoxicity by Polystyrene Nanoplastics Exacerbates High‐Fat Diet‐Induced Pediatric MAFLD Through Circadian Disruption and Mitochondrial Dysfunction

    by Peihao Xu, Shuting Huang, Leilei Zhu, Junyi Huang, Kewei Li, Guangming Li, Jiannong Wu, Mingyuan Zhou, Fangmei Zhou, Zhishan Ding, et al.

    Environmental nanoplastic exposure is increasingly recognized as a contributor to metabolic dysfunction, yet its impact on susceptibility to diet‐induced metabolic dysfunction‐associated fatty liver disease (MAFLD) during development remains unclear. Here, we show that polystyrene nanoplastics (PS‐NPs) exacerbate high‐fat diet (HFD)‐induced hepatic steatosis in an age‐dependent manner. In juvenile, but not adult, mice, PS‐NPs augmented HFD‐driven dyslipidemia, hepatomegaly, and hepatic lipid accumulation without altering energy intake. Mechanistic analyses revealed disruption of the hepatic circadian‐mitochondrial axis, including altered clock gene programs, impaired AMP‐activated protein kinase (AMPK) signaling, mitochondrial dysfunction, and suppressed oxidative metabolism. In hepatocytes, PS‐NPs potentiated free‐fatty‐acid‐induced circadian misalignment, mitochondrial impairment, oxidative stress, and lipid accumulation. AMPK activation by AICAR alleviated steatosis and mitochondrial defects, whereas circadian modulation by SR9009 improved mitochondrial function and hepatocellular injury, highlighting distinct protective mechanisms. Collectively, these findings define early life as a critical window of vulnerability to combined environmental and dietary stressors and introduce the concept of chronotoxicity, the capacity of environmental exposures, such as PS‐NPs, to perturb circadian timing and temporal metabolic organization‐linking nanoplastic exposure to pediatric MAFLD.

  • Histone Deacetylase 7 Exacerbates the Inflammatory Response by Inhibiting Nur77 Expression to Induce Lesions of Acute Respiratory Distress Syndrome

    by Dongdong Yang, Rong Zhou, Chenjuan Wang, Mengyuan Shen, Zejiong Li, Yiheng Fu, Jiannong Wu

    Acute respiratory distress syndrome (ARDS) is an acute respiratory disease. Nuclear receptor 77 (Nur77) shows anti‐ARDS activity. Histone deacetylase 7 (HDAC7) knockdown suppresses inflammatory response in acute lung injury, but its role in ARDS remains unclear. ARDS mouse models were established by cecum ligation and puncture. Assessment of lung function indexes, HE staining, immunohistochemistry, ChIP, and proteomics were performed. In vitro, human non‐small cell lung cancer A549 cells were treated with lipopolysaccharide (LPS), and qRT‐PCR, CCK8, and flow cytometry were conducted. Silencing of HDAC7 and Nur77, ELISA, and Western blot analysis were performed both in vivo and in vitro. ARDS mice exhibited lower pH, partial pressure of oxygen (PaO 2 ), arterial oxygen saturation, PaO 2 /fraction of inspiration oxygen, and higher partial pressure of carbon dioxide (PaCO 2 ) and protein levels in bronchoalveolar lavage fluid. In ARDS mice, HDAC7 knockdown inhibited inflammatory infiltration, reduced tumor necrosis factor‐α (TNF‐α), interleukin (IL)‐1β, IL‐6, and HDAC7 levels, and enhanced zonula occludens‐1, Occludin, Claudin‐1, and Nur77 expression, which reversed by Nur77 knockdown. Moreover, the crucial differentially expressed proteins included Igkv14‐126, IGLC2, Prss3b, Ccdc50, and Chchd7. HDAC7 bound to Nur77 promoter. Notably, Ccdc50 over‐expression enhanced the mitigating effect of Nur77 over‐expression on inflammatory response and impaired barrier function aggravated by HDAC7 over‐expression in ARDS mice. In LPS‐treated cells, HDAC7 knockdown reduced TNF‐α, IL‐1β, IL‐6 levels, and apoptosis, and increased cell viability, which also reversed by Nur77 knockdown. HDAC7 may inhibit Nur77 to exacerbate ARDS by upregulating Igkv14‐126, IGLC2, Prss3b, and downregulating Ccdc50 and Chchd7, offering new targets for ARDS treatment.

  • Open Access

    Knowledge, attitude and practice of patients with functional gastrointestinal disorders toward their diseases: a web-based cross-sectional study in a Chinese outpatient setting

    by Chenjuan Wang, Zhekai Ying, Rong Zhou, Yiling Luo, Tianchen Lin, Mengyuan Shen, Jiannong Wu

    Objectives: This study aimed to investigate the knowledge, attitude and practice (KAP) of patients living with functional gastrointestinal disorders (FGIDs) toward their diseases. Design: A web-based cross-sectional study was conducted. Setting: The gastroenterology outpatient department of Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang, China. Participants: The study enrolled 503 patients with FGIDs from the Gastroenterology Outpatient Department of our hospital between September and October 2023. Interventions: Not applicable for cross-sectional study. Primary and secondary outcome measures: Participants completed a self-designed questionnaire that collected sociodemographic information and assessed KAP scores. The primary outcome measures were KAP scores. Results: The mean KAP scores were 6.57±2.76 (possible range: 0–10) for knowledge, 30.00±4.08 (possible range: 7–35) for attitude and 30.16±4.92 (possible range: 8–40) for practice. Pearson’s correlation analysis indicated a positive and moderate correlation between knowledge and attitude (r=0.330, p<0.001), a weak positive correlation between knowledge and practice (r=0.152, p=0.001) and a weak positive correlation between attitude and practice (r=0.132, p=0.003). Structural equation model analysis revealed that drinking (estimate=−0.979, p=0.016) and household income (estimate=0.388, p<0.001) directly affected knowledge. Furthermore, knowledge (estimate=0.486, p<0.001) directly influenced attitude, while knowledge (estimate=0.206, p=0.015) and attitude (estimate=0.112, p=0.045) directly affected practice. Conclusions: Patients with FGIDs demonstrated moderate knowledge, positive attitudes and moderate practices regarding their disease. Drinking habits and household income reportedly influenced their KAP outcomes. Targeted educational interventions are warranted to enhance practice behaviours among patients with FGIDs.


  • Efficacy of exercise therapies on functional dyspepsia: A systematic review and meta-analysis

    by Zhiyan Huang, Yue Zhuang, Tianchen Lin, Shan Liu, Jiannong Wu


  • Open Access

    Considerations on multi-dimensional optimization of the CPR muscle fatigue mechanism

    by Meng-Yuan Shen, Rong Zhou, Jian-Nong Wu

  • Open Access

    Impact of complement C3 levels on the development of healthcare-associated infections in intensive care patients: a retrospective case-control study

    by Chenjuan Wang, Binhao Chen, Zhekai Ying, Mengyuan Shen, Yiling Luo, Tianchen Lin, Dandan Feng, Dongdong Yang, Zhongheng Zhang, Jiannong Wu

    The immune system serves as a critical line of defence against pathogenic microorganisms. To investigate the impact of immune markers, measured within the first 48 h of intensive care unit (ICU) admission, on the incidence of healthcare-associated infections (HAIs) in ICU patients. This case-control study included 364 patients admitted from 1 January 2020 to 30 November 2023, receiving immune marker testing within 48 h of ICU admission. Cox proportional hazard models and propensity score matching evaluated immune markers' association with HAIs risk. Log-rank tests compared time-to-event by C3 levels. All data processing and analysis were performed using R version 4.2.0 (R Foundation for Statistical Computing, Vienna, Austria) and Python version 3.11 (Python Software Foundation, Wilmington, DE). In total, 258 patients without HAIs (mean [SD] age, 67.24 [17.79] years) and 106 patients with HAIs (mean [SD] age, 73.80 [14.93] years) were included in the final analysis. The HAIs group had older age, longer hospital stay, lower Sequential Organ Failure Assessment (SOFA) scores, and a higher rate of comorbid infections than the non-HAIs group. Also, the HAIs group had a higher proportion of basophils, lymphocytes, monocytes and T suppressor cells (CD3 + CD8+), while the proportion of neutrophils and B cells (CD19+) was lower. After Cox regression analysis and propensity score adjustment, we found that C3 complement levels (HR: 0.40; 95%CI, 0.16-0.98; p = .044) influenced the incidence of HAIs. Patients were then divided into high C3 and low C3 groups based on a cut-off value of 0.455 for C3. A time-to-event plot showed that the median time to HAIs occurrence was nine days in the high C3 group and six days in the low C3 group (p = .048). Elevated complement C3 levels may associat with a reduced incidence of HAIs in ICU patients.


  • Open Access

    Microbiome modulators in the treatment of infectious diseases: insights from clinical trials

    by Shidong Wang, Chenjuan Wang, Linhua Shen, Mengjin Zhu, Jiannong Wu


  • Open Access

    Magnolol protects against acute gastrointestinal injury in sepsis by down-regulating regulated on activation, normal T-cell expressed and secreted

    by Shi-Hao Mao, Dan-Dan Feng, Xi Wang, Yi-Hui Zhi, Shu Lei, Xi Xing, Rong-Lin Jiang, Jian-Nong Wu

    Sepsis is a major medical challenge. Magnolol is an active constituent of Houpu that improves tissue function and exerts strong anti-endotoxin and anti-inflammatory effects, but the mechanism by which it reduces intestinal inflammation in sepsis is yet unclear. To assess the protective effect of magnolol on intestinal mucosal epithelial cells in sepsis and elucidate the underlying mechanisms. Enzyme-linked immunosorbent assay was used to measure tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, and regulated on activation, normal T-cell expressed and secreted (RANTES) levels in serum and ileal tissue in animal studies. The histopathological changes of the ileal mucosa in different groups were observed under a microscope. Cell Counting Kit-8 and cell permeability assays were used to determine the concentration of drug-containing serum that did not affect the activity of Caco2 cells but inhibited lipopolysaccharide (LPS)-induced decrease in permeability. Immunofluorescence and Western blot assays were used to detect the levels of RANTES, inhibitor of nuclear factor kappa-B kinase β (IKKβ), phosphorylated IKKβ (p-IKKβ), inhibitor of nuclear factor kappa-B kinase α (IκBα), p65, and p-p65 proteins in different groups in vitro. In rats treated with LPS by intravenous tail injection in the presence or absence of magnolol, magnolol inhibited the expression of proinflammatory cytokines, IL-1β, IL-6, and TNF-α in a dose-dependent manner. In addition, magnolol suppressed the production of RANTES in LPS-stimulated sepsis rats. Moreover, in vitro studies suggested that magnolol inhibited the increase of p65 nucleation, thereby markedly downregulating the production of the phosphorylated form of IKKβ in LPS-treated Caco2 cells. Specifically, magnolol inhibited the translocation of the transcription factor nuclear factor-kappa B (NF-κB) from the cytosol into the nucleus and down-regulated the expression level of the chemokine RANTES in LPS-stimulated Caco2 cells. Magnolol down-regulates RANTES levels by inhibiting the LPS/NF-κB signaling pathways, thereby suppressing IL-1β, IL-6, and TNF-α expression to alleviate the mucosal barrier dysfunction in sepsis.